Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Kane Biotech Receives Offer for its Interest in STEM Animal Health
-
Operation Come Home provides a welcoming and warm place for youth, thanks to an Ontario Trillium Foundation grant
-
Southern Michigan Bancorp, Inc. Declares Cash Dividend
-
Organic Remedies Honors U.S. Veterans Laid to Rest at Pennsylvania Military Cemeteries
-
IBN Announces Latest Episode of The Bell2Bell Podcast featuring Beau Kelley, CEO of Mountain Top Properties Inc., and Joseph Kelley, CEO of On Site Builder Construction Co. Inc.
-
Lumine Group to Acquire Device Management and Service Management Platform Businesses from Nokia
-
Nokia announces deal to sell Device Management and Service Management Platform businesses to Lumine Group
-
Inter&Co presents new brand and consolidates position as financial Super App
-
Inter&Co presents new brand and consolidates position as financial Super App
-
Nonprofit BlinkNow Provides Aid for Jajarkot Earthquake Crisis in Nepal
-
VÍS: Viðskipti stjórnanda
-
Purple Biotech Appoints Dr. Yael Margolin to its Board of Directors
-
Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference
-
BlackRock® Canada Announces Estimated Annual Reinvested Capital Gains Distributions for the iShares® ETFs
-
NevGold Announces C$1M Non-Brokered Private Placement Financing
-
United Nations High Commissioner for Refugees Awards Polar Power Initial Contract to Assure Uninterrupted Quality Electric Power for African Offices
-
Pacvue Accelerates Growth with New Key Hires
-
Madison Realty Capital Originates $177.5 Million Loan for 451-Unit Multifamily Development in Boston
-
OneMove Capital Ltd. Decreases Ownership Position in Dye & Durham to Below 10%
-
Gildan Activewear Directors Issue Open Letter to Shareholders
-
BlackRock® Canada Announces Estimated December Cash Distributions for the iShares® ETFs
-
Lipella Pharmaceuticals Marks Successful First Year with Strategic Progress and Key Milestones Accomplished
-
KULR Announces Pricing of $900,000 Public Offering of Common Stock
-
LianBio Announces Departure of Chief Financial Officer
-
Daré Bioscience Announces Positive Topline Pharmacokinetic and Exploratory Efficacy Results from the DARE-PDM1 Phase 1 Clinical Study
-
Poptential™ by Certell Offers Free Lessons on the Importance and History of Global Trade
-
TRACON Pharmaceuticals Provides Positive Update on Ongoing ENVASARC Pivotal Phase 2 Trial
-
Longeveron Announces Additional Positive Clinical Data and Imaging Biomarker Results from the CLEAR MIND Phase 2a Trial of Lomecel-B™ in the Treatment of Mild Alzheimer’s Disease
-
Open Lending Publishes Inaugural ESG Report
-
Crown Castle Announces Comprehensive Fiber Review and Additions to the Board
-
TransnetBW and RCM Technologies to Partner on Energy Transition
-
MBX Biosciences to Participate in 42nd Annual J.P. Morgan Healthcare Conference
-
2024 Economic Outlook Forecasts 2.2% Expansion in Equipment and Software Investment, 1.7% GDP Growth
-
Kondux Reveals New Vision for Customizable and Interoperable Experiences in Web3 Environments
-
WiMi Announced the Optimization of Artificial Neural Networks Using Group Intelligence Algorithm
-
Compass Diversified to Host Investor Day on January 17, 2024 in Newport Beach, California
-
Gorilla Expands Global Presence with New Distribution Company in Egypt and Commits to Invest Up to $100 Million to Support Regional Growth
-
red violet Announces Additional $5 Million Share Repurchase Authorization
-
Locafy Regains Compliance with Nasdaq Stockholders’ Equity Requirement
-
BrewBilt Brewing Company Annual Update
-
Phosphorus Raises $27 Million Series A2 Financing Round Led by Evolution Equity Partners
-
BioAtla to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
-
Alpine Beer’s Fan-Favorite ‘Windows Up’ IPA Returns With Its Signature Tropical Dankness
-
Ardelyx, Inc. Reports Employment Inducement Grants
-
Myriad Genetics Establishes Comprehensive Pan-Cancer Research Platform to Advance Patient Care
-
Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
-
Martela specifies its revenue guidance for 2023
-
Jotul AS successfully places NOK 510 million of senior secured floating rate bonds
-
VEON Presents Digital Operator Success Story at NSR/BCG Investor Conference in New York
-
Recursion and Enamine to Generate and Design Enriched Compound Libraries for Global Drug Discovery Industry


